NovelStem International Corp. (NSTM)
Develops cancer diagnostic technology to improve chemotherapy effectiveness.
$0.01+0.30%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-50.0%
The outlook
NSTM is trading near its 52-week lows with a mixed technical picture relative to moving averages. Analyst coverage appears thin or absent, and the overall sentiment leans bearish. The stock's extremely low price and positioning suggest it remains a speculative micro-cap.
What’s behind the score
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Market cap
$641,321
52-wk high
$0.04
52-wk low
$0.01
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
0.3